-
公开(公告)号:WO2021091819A
公开(公告)日:2021-05-14
申请号:PCT/US2020/058526
申请日:2020-11-02
Applicant: RECURIUM IP HOLDINGS, LLC [US]/[US]
Inventor: HUANG, Peter, Qinhua , HEGDE, Sayee, Gajanan , BUNKER, Kevin, Duane , KNIGHT, John , SLEE, Deborah, Helen
IPC: C07D471/04 , A61P35/00
Abstract: Salts of Compound A and forms described herein are estrogen receptor alpha modulators. Such salts and/or forms can be are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as breast cancer.